Aging drives cellular and cognitive impairments in the adult brain. It is imperative to gain mechanistic insight into what drives aging phenotypes in the brain in order to maintain, and even restore, functional integrity in the elderly. We, and others, have shown that systemic manipulations - such as heterochronic parabiosis (in which a young and...

The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. Join us for three days in Boston for the most...

MassBio's State of Possible Conference is the premier event for the Massachusetts life sciences industry. Attendees from the lab to the c-suite will experience a packed, ‘can’t miss’ agenda featuring top pharmaceutical and biotech leaders taking the stage to speak to the conference theme of Meeting the Moment. Experience engaging panel discussions on surviving biotech’s choppy waters and...

WHAT YOU'LL LEARN AT THIS COMMERCIAL REAL ESTATE LIFE SCIENCES CONFERENCE What continues to drive the investment appetite for the life sciences sector within the Mid-Atlantic region? Between construction costs and rising interest rates, how has the impact of the last few months affected current projects? What strategies are being implemented to navigate through these...

This year’s Align Summit, a partnering event for funders and early-stage companies, will focus on artificial intelligence and machine learning in drug discovery and development with insights from our partners Locust Walk and McKinsey & Company. We will explore this topic through four panel discussions from the perspective of biotech or AI/ML. The Align Summit will include...

What You'll Learn: How is the capital markets slowdown and rising interest rates impacting the current growth of the biotech sector? Understand where New York ranks nationally with life sciences developments and what the future hold for this market. Which life sciences developments are best in class in New York and what is driving tenants...

Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers. Join for a conversation with past all-star Wunderkinds to see where they are now, how their journeys have unfolded, and hear their most inspiring and innovative ideas.  

Access to health care is directly impacted by decisions being made by policymakers. STAT’s DC reporters will take a deep dive into how we can ensure patient care is remaining a top priority on the hill during this election year. Join us for an evening with patient advocates, policymakers, and industry leaders to discuss how...

Join our panel of experts as we explore a spectrum of topics, including the latest regulatory updates and effective strategies to navigate them. We'll discuss the impact of the current financial landscape on various biotech companies, the optimal pathway for nonclinical gene therapy development, and how ethnobridging can significantly accelerate project timelines. This complimentary event...